Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$18.97 - $31.47 $2.01 Million - $3.33 Million
-105,900 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$18.25 - $23.0 $755,550 - $952,200
-41,400 Reduced 28.11%
105,900 $2.43 Million
Q2 2018

Aug 08, 2018

SELL
$13.95 - $19.15 $1.6 Million - $2.2 Million
-114,900 Reduced 43.82%
147,300 $2.81 Million
Q1 2018

May 10, 2018

SELL
$14.05 - $20.2 $1.7 Million - $2.45 Million
-121,200 Reduced 31.61%
262,200 $4.42 Million
Q4 2017

Feb 12, 2018

BUY
$12.85 - $18.1 $372,650 - $524,900
29,000 Added 8.18%
383,400 $5.83 Million
Q3 2017

Nov 13, 2017

BUY
$15.4 - $18.85 $5.46 Million - $6.68 Million
354,400
354,400 $6.34 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $286M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.